Read + Share
Woo EJ, Moro PL. Postmarketing safety surveillance of quadrivalent recombinant influenza vaccine:
Reports to the vaccine adverse event reporting system. Vaccine 2021 Mar 4. pii: S0264-410X(21)00232.
PMID: 33678452
|
 |
|
Woo EJ, Moro PL. Postmarketing safety surveillance of quadrivalent recombinant influenza vaccine:
Reports to the vaccine adverse event reporting system. Vaccine 2021 Mar 4. pii: S0264-410X(21)00232.
PMID: 33678452
|
|
|
|